Cargando…
Refractory necrotizing scleritis successfully treated with adalimumab
Necrotizing scleritis is the most severe and destructive form of scleritis with vision-threatening sequelae. It is divided into with inflammation and without inflammation (scleromalacia perforans). Adalimumab is a tumour necrosis factor (TNF)-inhibiting anti-inflammatory medication licensed for the...
Autores principales: | Lawuyi, Lola E., Gurbaxani, Avinash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059540/ https://www.ncbi.nlm.nih.gov/pubmed/27734292 http://dx.doi.org/10.1186/s12348-016-0107-y |
Ejemplares similares
-
The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery
por: Lawuyi, Lola Elizabeth, et al.
Publicado: (2015) -
Necrotizing scleritis in a case of Vogt-Koyanagi-Harada disease
por: Sambhav, Kumar, et al.
Publicado: (2015) -
A Case of Isotretinoin Therapy-Refractory Folliculitis Decalvans Treated Successfully with Biosimilar Adalimumab (Exemptia)
por: Shireen, Furtado, et al.
Publicado: (2018) -
Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis
por: Chen, Binyao, et al.
Publicado: (2022) -
Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis
por: Bawazeer, Ahmed M., et al.
Publicado: (2011)